共 1 页 当前第 1 页 返回检索页| 1 | 药品名称 | AVANDAMET |
| 申请号 | 021410 | 产品号 | 001 |
| 活性成分 | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 500MG;EQ 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2002/10/10 | 申请机构 | SB PHARMCO PUERTO RICO INC
|
| 2 | 药品名称 | AVANDAMET |
| 申请号 | 021410 | 产品号 | 002 |
| 活性成分 | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 500MG;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2002/10/10 | 申请机构 | SB PHARMCO PUERTO RICO INC
|
| 3 | 药品名称 | AVANDAMET |
| 申请号 | 021410 | 产品号 | 003 |
| 活性成分 | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 500MG;EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2002/10/10 | 申请机构 | SB PHARMCO PUERTO RICO INC
|
| 4 | 药品名称 | AVANDAMET |
| 申请号 | 021410 | 产品号 | 004 |
| 活性成分 | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 1GM;EQ 2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2003/08/25 | 申请机构 | SB PHARMCO PUERTO RICO INC
|
| 5 | 药品名称 | AVANDAMET |
| 申请号 | 021410 | 产品号 | 005 |
| 活性成分 | METFORMIN HYDROCHLORIDE; ROSIGLITAZONE MALEATE | 市场状态 | 停止上市 |
| 剂型或给药途径 | TABLET;ORAL | 规格 | 1GM;EQ 4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons** |
| 治疗等效代码 | | 参比药物 | 否 |
| 批准日期 | 2003/08/25 | 申请机构 | SB PHARMCO PUERTO RICO INC
|